Year: 2021
Categories Multiple Myeloma

Martin Compares Triplet and Quadruplet Therapies in Newly Diagnosed Multiple Myeloma

Martin Compares Triplet and Quadruplet Therapies in Newly Diagnosed Multiple Myeloma During a virtual Targeted Oncology Case-Based Rountable, Thomas G. Martin, MD, a clinical professor of Medicine, associate director, Myeloma Program ,and coleader, Hematopoietic Malignancies Program, at the Helen Diller Family Comprehensive Cancer Center of University of California, San Francisco, discussed triplet and quadruplet combination […]

Read More
Categories Parkinson's Disease

New Global Research: Veterinary ECG Market Size, Key Trends, Growth, Price, Review, Share, Analysis

Intense Research releases a new market research report “Global and China Veterinary ECG Market – Industry Analysis, Size, Share, Growth and Forecasts 2016-2021” to add to its collection of research reports. The ‘Global and Chinese Veterinary ECG Market, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global […]

Read More
Categories Cancer

Increased Number of Plasma Cells Found in Black Men with Prostate Cancer, Associated With …

Increased Number of Plasma Cells Found in Black Men with Prostate Cancer, Associated With … The increased proportion of plasma cell infiltrate and augmented markers of natural killer (NK)–cell activity and IgG expression in tumors of Black compared with White men is associated with improved recurrence-free survival following surgery, according to data published in Nature […]

Read More
Categories Cancer

CRISPR-based cancer therapies likely to be a disruptive technology in healthcare: GlobalData

CRISPR-based cancer therapies likely to be a disruptive technology in healthcare: GlobalData Read Article Clustered regularly interspaced short palindromic repeat (CRISPR) therapies are one of the most potentially powerful and transformative technologies in human history, according to GlobalData. Expected to be able to prolong the life of cancer patients by decades, compared to the current […]

Read More
Categories Multiple Myeloma

Zacks: Brokerages Expect BeiGene, Ltd. (NASDAQ:BGNE) Will Post Earnings of -$3.47 Per Share

Zacks: Brokerages Expect BeiGene, Ltd. (NASDAQ:BGNE) Will Post Earnings of -$3.47 Per Share Analysts predict that BeiGene, Ltd. (NASDAQ:BGNE) will announce earnings per share (EPS) of ($3.47) for the current quarter, Zacks reports. Two analysts have made estimates for BeiGene’s earnings. The lowest EPS estimate is ($4.77) and the highest is ($1.04). BeiGene reported earnings […]

Read More
Categories Multiple Myeloma

Highlighting Resiliency During Multiple Myeloma Awareness Month 2021

Highlighting Resiliency During Multiple Myeloma Awareness Month 2021 Multiple myeloma is not easily diagnosed, and its early symptoms may be confused for another condition. Each March, Multiple Myeloma Awareness Month puts multiple myeloma (MM) in the spotlight. A rare cancer, MM is not easily diagnosed early on, but it is the second most common blood […]

Read More
Categories Cancer

Oncology Professionals Look Back and Ahead at Cancer Care After A Year of COVID-19

Oncology Professionals Look Back and Ahead at Cancer Care After A Year of COVID-19 Reflecting on the impact of the COVID-19 pandemic, a panel of oncology professionals at the Association of Community Cancer Centers’ (ACCC) 47th Annual Meeting and Cancer Center Business Summit discussed the permanent paradigm shifts in oncology and how they responded, and […]

Read More
Categories Cancer

University of Glasgow: EUROPEAN CONSORTIUM TO USE AI TO IMPROVE PANCREATIC …

University of Glasgow: EUROPEAN CONSORTIUM TO USE AI TO IMPROVE PANCREATIC … University of Glasgow: EUROPEAN CONSORTIUM TO USE AI TO IMPROVE PANCREATIC CANCER TREATMENT – India Education,Education News India,Education News | India Education Diary Home Academics University of Glasgow: EUROPEAN CONSORTIUM TO USE AI TO IMPROVE PANCREATIC CANCER TREATMENT Published at Fri, 12 Mar […]

Read More